233 related articles for article (PubMed ID: 21747047)
1. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study.
Zhang Y; Agnoletti D; Safar ME; Blacher J
Hypertension; 2011 Aug; 58(2):155-60. PubMed ID: 21747047
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial.
Huffman MD; Baldridge AS; Lazar D; Abbas H; Mejia J; Flowers FM; Quintana A; Jackson A; Kandula NR; Lloyd-Jones DM; Persell SD; Khan SS; Paparello JJ; Chopra A; Tripathi P; Vu MH; Chow CK; Ciolino JD
Hypertens Res; 2024 Jun; 47(6):1668-1677. PubMed ID: 38584159
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a single-pill versus free combination of perindopril/indapamide/amlodipine: a multicenter, randomized, double-blind study in Chinese patients with hypertension.
Wang JG; Topouchian J; Bricout-Hennel S; Mu J; Chen L; Li P; He S; Luo S; Jiang W; Jiang Y; Sun Y; Zhang Y; Asmar R
J Hypertens; 2024 Aug; 42(8):1373-1381. PubMed ID: 38660708
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
6. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study.
Emeriau JP; Knauf H; Pujadas JO; Calvo-Gomez C; Abate G; Leonetti G; Chastang C;
J Hypertens; 2001 Feb; 19(2):343-50. PubMed ID: 11212979
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
Chrysant SG; Marbury TC; Robinson TD
J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
[TBL] [Abstract][Full Text] [Related]
8. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure.
Kario K; Shimada K
Am J Hypertens; 1997 Mar; 10(3):261-8. PubMed ID: 9056682
[TBL] [Abstract][Full Text] [Related]
10. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
Ibrahim MM; el-Boghdadly B; Zaghloul SS
J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
[TBL] [Abstract][Full Text] [Related]
12. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes.
Kuo SW; Pei-Dee ; Hung YJ; Hsieh AT; Wu LY; Hsieh CH; He CT; Yang TC; Lian WC
Am J Hypertens; 2003 Aug; 16(8):623-8. PubMed ID: 12878366
[TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension in elderly individuals].
Ambrosioni E
Presse Med; 2002 Oct; 31 Spec No 2():S17-20. PubMed ID: 12356000
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.
Nolde JM; Atkins E; Marschner S; Hillis GS; Chalmers J; Billiot L; Nelson MR; Reid CM; Hay P; Burke M; Jansen S; Usherwood T; Rodgers A; Chow CK; Schlaich MP
J Hypertens; 2024 Jun; 42(6):1009-1018. PubMed ID: 38501351
[TBL] [Abstract][Full Text] [Related]
15. Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension.
Ostergren J; Isaksson H; Brodin U; Schwan A; Ohman KP
Am J Hypertens; 1998 Jun; 11(6 Pt 1):690-6. PubMed ID: 9657628
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
Donnelly R
Clin Pharmacokinet; 1999; 37 Suppl 1():21-32. PubMed ID: 10491730
[TBL] [Abstract][Full Text] [Related]
17. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies.
Mallion JM; Asmar R; Boutelant S; Guez D
J Cardiovasc Pharmacol; 1998 Oct; 32(4):673-8. PubMed ID: 9781939
[TBL] [Abstract][Full Text] [Related]
19. Irbesartan reduces QT dispersion in hypertensive individuals.
Lim PO; Nys M; Naas AA; Struthers AD; Osbakken M; MacDonald TM
Hypertension; 1999 Feb; 33(2):713-8. PubMed ID: 10024334
[TBL] [Abstract][Full Text] [Related]
20. Clinical positioning of indapamide sustained release 1.5mg in management protocols for hypertension.
Leonetti G
Drugs; 2000; 59 Suppl 2():27-38; discussion 39-40. PubMed ID: 10678595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
